Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
How custom works Your reason, composed into a plan
Clinical trials demonstrate that meaningful weight reductiontypically defined as 5% or more of initial body weightgenerally occurs over 36 months
However, determining whether GLP-1 therapy is the best choice for someone should be based on a detailed talk with their doctor that includes a complete review of the persons medical history, their health status, and clarity about their long-term treatment goals
NDA filed with FDA
15 May 2025 Obesity drugs found to improve emotional wellbeing as well as physical health A major new meta-analysis from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at Kings College London has found that glucagon-like peptide 1 receptor agonists (GLP1- RAs) - a class of medications used to treat obesity and diabetes may also offer benefits for emotional wellbeing in overweight users
